American Healthcare REIT, Inc. (NYSE:AHR - Get Free Report) EVP Mark Foster sold 2,000 shares of the business's stock in a transaction on Monday, November 16th. The shares were sold at an average price of $57.99, for a total value of $115,980.00. Following the completion of the sale, the executive vice president directly owned 48,117 shares in the company, valued at approximately $2,790,304.83. This represents a 3.99% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
American Healthcare REIT Price Performance
NYSE:AHR traded down $0.23 during trading hours on Tuesday, reaching $57.84. The company had a trading volume of 2,124,700 shares, compared to its average volume of 3,000,736. The company has a quick ratio of 0.48, a current ratio of 0.53 and a debt-to-equity ratio of 0.15. The stock has a 50-day moving average of $53.45 and a two-hundred day moving average of $52.01. American Healthcare REIT, Inc. has a one year low of $44.81 and a one year high of $59.54. The firm has a market capitalization of $13.42 billion, a PE ratio of 118.03, a PEG ratio of 1.39 and a beta of 0.78.
American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.56 by $0.02. American Healthcare REIT had a return on equity of 2.38% and a net margin of 3.61%. The company had revenue of $742.15 million during the quarter, compared to analysts' expectations of $703.51 million. During the same period last year, the business earned $0.44 earnings per share. The business's revenue was up 29.5% on a year-over-year basis. Analysts forecast that American Healthcare REIT, Inc. will post 2.26 earnings per share for the current year.
American Healthcare REIT Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, October 16th. Shareholders of record on Wednesday, September 30th were given a $0.25 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.00 dividend on an annualized basis and a yield of 1.7%. American Healthcare REIT's payout ratio is 204.08%.
Institutional Investors Weigh In On American Healthcare REIT
Several hedge funds and other institutional investors have recently added to or reduced their stakes in AHR. Outlook Capital Management LLC acquired a new position in shares of American Healthcare REIT during the second quarter worth approximately $25,000. Manning & Napier Advisors LLC acquired a new stake in shares of American Healthcare REIT in the second quarter valued at approximately $28,000. Silver Grove Financial Group Inc. increased its holdings in shares of American Healthcare REIT by 1,065.5% in the third quarter. Silver Grove Financial Group Inc. now owns 641 shares of the company's stock valued at $33,000 after purchasing an additional 586 shares in the last quarter. Covestor Ltd increased its holdings in shares of American Healthcare REIT by 297.8% in the third quarter. Covestor Ltd now owns 720 shares of the company's stock valued at $37,000 after purchasing an additional 539 shares in the last quarter. Finally, Jacobi Capital Management LLC bought a new position in American Healthcare REIT in the 3rd quarter worth approximately $46,000. Institutional investors and hedge funds own 16.68% of the company's stock.
Analyst Ratings Changes
A number of research firms have recently issued reports on AHR. Raymond James Financial reiterated a "strong-buy" rating and issued a $72.00 target price on shares of American Healthcare REIT in a research note on Tuesday, November 10th. UBS Group increased their price target on American Healthcare REIT from $62.00 to $71.00 and gave the stock a "buy" rating in a research report on Wednesday, November 11th. Barclays dropped their price target on American Healthcare REIT from $66.00 to $60.00 and set an "overweight" rating for the company in a report on Tuesday, October 13th. KeyCorp lifted their price objective on American Healthcare REIT from $58.00 to $68.00 and gave the company an "overweight" rating in a research report on Wednesday, August 19th. Finally, Compass Point initiated coverage on American Healthcare REIT in a research report on Tuesday, July 21st. They issued a "buy" rating and a $70.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating and thirteen have given a Buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $64.00.
View Our Latest Research Report on American Healthcare REIT
American Healthcare REIT Company Profile
(
Get Free Report)
American Healthcare REIT is a real estate investment trust focused on healthcare-related properties. Its portfolio includes senior housing and care communities, skilled nursing facilities, outpatient medical buildings, and integrated senior health campuses. The company owns and operates properties across the United States and the United Kingdom. Its facilities support a range of healthcare and senior living services, including assisted living, memory care, and post-acute care. American Healthcare REIT began trading on the New York Stock Exchange in 2024.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.